CHARLOTTE, NORTH CAROLINA, March 7, 2008 - Clayton Tolley, President and CEO of Addison Whitney, was recently requested to host a pharmaceutical webinar for the Center for Business Intelligence (CBI). CBI was founded in 1994 and is dedicated to developing conferences in pharmaceuticals, biotechnology, medical devices, risk and insurance and managed care markets. The webinar will address key considerations for successful FDA/EMEA naming approvals and will be held on April 9 at 3:30 PM EST. Tolley will focus on lessons learned from FDA and EMEA approval processes, how names can mitigate the likelihood of a medication error and how to create a successful strategy for gaining name approval the first time.
“Due to a diverse client base, Addison Whitney has gained a rare insight into the pharmaceutical and biotechnology industry,” stated Tolley. “I am excited for this opportunity to share lessons we have learned through interaction with the FDA and EMEA and our process for creating a successful naming strategy to mitigate the likelihood of a medication error. Medication error is a grave issue. In 2006, the Institute of Medicine of the National Academies reported that medication errors harm at least 1.5 million people annually, and that confusion caused by similar drug names accounts for up to 25 percent of all errors reported to the Medication Error Reporting Program.”
For more information, please call Lizzy Guterma at 704-697-4055 or email@example.com
or visit www.addisonwhitney.com
About Addison Whitney
Addison Whitney is a global full-service brand consulting firm. Founded in 1991, the firm has extended its services to offer branding expertise in the areas of verbal branding, visual branding, brand strategy, and research and analysis. Clients come to Addison Whitney from industries including: consumer, technology, business to business and other market segments. Addison Whitney health, a specialized healthcare division of Addison Whitney, serves the branding needs of pharmaceutical, biotechnology, life science, and medical specialties. For more information, visit www.addisonwhitney.com
« BACK TO PRESS RELEASES